Webinars, Pharmaceutical

From pMDI Device to Therapeutic Effect

Pressurized metered dose inhalers, a critical solution for routine respiratory drug delivery, are currently the subject of considerable development activity. As manufacturers tackle the transition to low GWP (Global Warming Potential) propellants alongside evolving requirements for connected devices and lower cost medicines the need for more effective tools for pMDI formulation and reformulation intensifies.

This webinar showcases SmartTrack™, a novel integrated solution from Aptar Pharma that accelerates pMDI development. SmartTrack™ incorporates in vitro and in silico techniques that characterize every important process from pMDI actuation to drug delivery to the patient, and includes an alternative approach to comparative clinical endpoint for demonstrating bioequivalence. It can reduce time-to-market and program costs by accelerating new product development and regulatory decision-making.

Learn more from our experts about the challenges of reformulation with low GWP propellants, the value of using an integrated suite of tools to address them, and what SmartTrack™ can deliver. Case study data from the reformulation of a well-known API with a low GWP propellant are presented.

Watch the webinar From pMDI Device to Therapeutic Effect
Speaker(s): Chris Baron Will Ganley
16 Nov 2022

Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery

Find Out More About pulmonary drug delivery expertise

This Might Also Be of Interest

3 Jul 2023

Leachables Assessment: New pMDI with Low-GWP Propellants

Publications, Pharmaceutical, Sustainability, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
3 Jul 2023

Performance of Low-GWP Propellants in pMDIs: Filling and Dose Evaluation

Publications, Pharmaceutical, Product Solutions, Sustainability, Device Innovations, Market Insights

Read More
3 Jul 2023

Orally Inhaled Drug products; Bioequivalence Models

Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation

Read More
10 May 2023

Navigating the Development for Orally Inhaled and Nasal Drug Products

Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
1 2 3 17

Request Access


Requesting access to From pMDI Device to Therapeutic Effect.

  • This field is for validation purposes and should be left unchanged.
Back To Top